Skip to content
Screener

Incyte INCY Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$207M+6.7%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$1.56M+1.4%
Geron logo
GeronGERN
$1.01M+2.6%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$2.4M+10.3%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$487K+29.2%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$19.23M+9.3%

Other financials

Income statement

See full
Revenue$1.7B+37.7%
Gross profit$1.6B+38.0%
Operating income$697.9M+31.6%
Net income$585.6M+44.6%
EPS (diluted)$2.81+37.7%

Balance sheet

See full
Cash & equivalents$4.0B+104%
Total debt$38.3M-9.8%
Total equity$6.3B+52.1%
Total assets$7.9B+35.2%

Cash flow

See full
Operating cash flow$507.7M+1,035%
CapEx$1.6M-43.5%
Free cash flow$509.3M+1,069%

Valuation

See full
Market cap$24.44B+58.0%
Enterprise value$20.49B+51.2%
P/E15.2×-2.6×
P/S4.2×+0.8×

Profitability

See full
Gross margin92.6%-0.3pp
Operating margin30.6%+4.8pp
Net margin27.7%+8.7pp
FCF margin34%+12.3pp

Returns & leverage

See full
Return on equity30.7%+6.4pp
Debt / equity0.0×
Current ratio4.6×+1.7×

Where this comes from

Reported directly by Incyte in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Incyte’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000879169-26-000056
Line itemJune 30,2026December 31,2025
Royalties$42,796$40,678
Clinical related costs164,368175,932
Sales allowances526,435642,468
Sales and marketing60,34171,248
Accrued taxes2,2394,755
Operating lease liabilities5,5885,697
Other current liabilities68,53990,723
Total accrued and other current liabilities$870,306$1,031,501

Item 1. Financial Statements

FAQ

What is Incyte's operating lease liabilities (current)?
Incyte (INCY) reported operating lease liabilities (current) of $5.59M in Q2 2026.
How has Incyte's operating lease liabilities (current) changed year-over-year?
Incyte's operating lease liabilities (current) decreased by 9.5% year-over-year, from $6.17M to $5.59M.
What is the long-term trend for Incyte's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Incyte's operating lease liabilities (current) has grown at a -14.8% compound annual growth rate (CAGR), from $12.67M to $5.7M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Incyte's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude